Literature DB >> 353416

Changes in striatal specific 3-H-atropine binding after unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurones.

G Kato, S Carson, M L Kemel, J Glowinski, M F Giorguieff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 353416     DOI: 10.1016/0024-3205(78)90056-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

Review 1.  Presynaptic regulation of dopaminergic transmission in the striatum.

Authors:  J Glowinski; A Chéramy; R Romo; L Barbeito
Journal:  Cell Mol Neurobiol       Date:  1988-03       Impact factor: 5.046

2.  Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.

Authors:  K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

3.  Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.

Authors:  O Giorgi; M C Rubio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

4.  Chronic sympathetic denervation increases muscarinic cholinoceptor binding in the rat submaxillary gland.

Authors:  C Pimoule; M Briley; S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

5.  A study of the role of the cholinergic system in amygdaloid kindling in rats.

Authors:  D H Blackwood; M J Martin; J G Howe
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.

Authors:  J S de Belleroche; I M Gardiner
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

7.  Effects of kainic acid on body temperature of rats: role of catecholaminergic and serotonergic systems.

Authors:  L Turski; Z Kleinrok
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.